Countries are unlikely to solve a particular problem unless they have some level of research invested in the effort. The approach in this paper is to use malaria research as a proxy for effective exploitation of local scientific knowledge. We study the malaria-related research output in two countries, Brazil and India, with among the most advanced science and pharmaceutical capabilities in the developing world. We assess local relevance of science and also its integration with international research by looking at almost 60 years of scientific publications on malaria between 1945-2003.
A preventive HIV vaccine offers the best hope for ending the AIDS pandemic. Scientific evidence suggests that an HIV vaccine is possible, and funding for HIV vaccine research and development (R&D) has increased substantially in recent years. The speed of progress toward an HIV vaccine will depend on the management of the effort as well as on its scale, however, and organizational issues have been the subject of vigorous debate.
Meet Jessica George, former aerospace engineer and M.S. candidate at the Urban Planning program at GSAPP. At TCLab our researchers' backgrounds boost their understanding of how economies change. Their training and commitment can bridge technological and industrial transformation to topics on urban and regional employment, health, and social protections.
Market Menagerie examines technological advance and market regulation in the health industries of nations such as India, Brazil, South Africa, Nigeria, and China. Pharmaceutical and life science industries can reinforce economic development and industry growth, but not necessarily positive health outcomes. Yet well-crafted industrial and health policies can strengthen each other and reconcile economic and social goals.
This paper suggests that demand instruments of international vaccine procurement, instead of being seen primarily as a global management instrument, can usefully induce industrial change and technological innovation through improved technical standards and regulations. The example of Indian vaccines is analyzed, and an industrial evolution schematic is investigated. The findings suggest that some fine tuning can improve the demand side for technological innovation.
This is a controversial and troubling question for nations and citizens (especially if they are feeling insecure). But daily reality brings more important questions than this: the need to find food, shelter, and preserve or improve one’s health. “Development” in the abstract is a little distracting if it doesn’t speak directly to these essential concerns. Are developed societies those with healthy citizens and residents?
The discussion elaborated on themes from Smita Srinivas's Market Menagerie: Health and Development in Late Industrial States—a far-reaching analysis of technological advance and market regulation of the biotech and pharmaceutical industries in India, Brazil, China, Nigeria, and South Africa—as a springboard into the difficult responsibilities of reporting across media and cultural divides.
The Technological Change Lab (TCLab) is a research and advisory program with international scope, with a focus on economic development in developing economies. Our focus is on processes of technological change - it's origins and implications in industry sectors, technological innovations, employment patterns, and urban and regional transformation. Every change involves considering questions of redistribution, equality, and inclusion - and what policies and planning processes will best meet these issues.